These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7525035)

  • 1. Serum-soluble interleukin-2 receptor concentrations in patients with gastric cancer.
    Murakami S; Satomi A; Ishida K; Murai H; Matsuki M; Hashimoto T
    Cancer; 1994 Nov; 74(10):2745-8. PubMed ID: 7525035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum soluble interleukin-2 receptor as a predictor of lymph node metastasis in early gastric cancer.
    Murakami S; Sakata H; Tsuji Y; Okubo K; Hamada S; Hirayama R
    Dig Surg; 2002; 19(1):9-13; discussion 14. PubMed ID: 11961349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
    Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
    Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum soluble interleukin-2 receptor in colorectal cancer.
    Murakami S; Satomi A; Ishida K; Murai H; Okamura Y
    Acta Oncol; 1994; 33(1):19-21. PubMed ID: 8142118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum level of a soluble receptor for interleukin-2 as a prognostic factor in patients with gastric cancer.
    Saito H; Tsujitani S; Ikeguchi M; Maeta M; Kaibara N
    Oncology; 1999 Apr; 56(3):253-8. PubMed ID: 10202282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
    Kim JH; Jun KH; Jung H; Park IS; Chin HM
    Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum soluble interleukin-2 receptor (IL-2R) and immunohistochemical staining of IL-2R/Tac antigen in colorectal cancer.
    Sakata H; Murakami S; Hirayama R
    Int J Clin Oncol; 2002 Oct; 7(5):312-7. PubMed ID: 12402066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinicopathological significance of preoperative serum-soluble interleukin-2 receptor concentrations in operable non-small-cell lung cancer patients.
    Kawashima O; Kamiyoshihara M; Sakata S; Endo K; Saito R; Morishita Y
    Ann Surg Oncol; 2000 Apr; 7(3):239-45. PubMed ID: 10791856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum soluble interleukin-2 receptor and immunohistochemical staining of IL-2R/Tac antigen in gastric cancer.
    Murakami S; Satomi A; Ishida K; Sakata H; Tsuji Y; Hibino S
    Oncol Rep; 1996 Jan; 3(1):69-73. PubMed ID: 21594317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum interleukin-12 levels in patients with gastric cancer.
    Murakami S; Okubo K; Tsuji Y; Sakata H; Hamada S; Hirayama R
    Surg Today; 2004; 34(12):1014-9. PubMed ID: 15580384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of preoperative serum carcinoembryonic antigen, CA 19-9 and alpha fetoprotein levels in gastric cancer patients.
    Nakajima K; Ochiai T; Suzuki T; Shimada H; Hayashi H; Yasumoto A; Takeda A; Hishikawa E; Isono K
    Tumour Biol; 1998; 19(6):464-9. PubMed ID: 9817974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.
    Feng F; Tian Y; Xu G; Liu Z; Liu S; Zheng G; Guo M; Lian X; Fan D; Zhang H
    BMC Cancer; 2017 Nov; 17(1):737. PubMed ID: 29121872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative serum levels of CA 72-4, CEA, CA 19-9, and alpha-fetoprotein in patients with gastric cancer.
    Mattar R; Alves de Andrade CR; DiFavero GM; Gama-Rodrigues JJ; Laudanna AA
    Rev Hosp Clin Fac Med Sao Paulo; 2002; 57(3):89-92. PubMed ID: 12118264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of No.12 lymph node dissection for advanced gastric cancer].
    You X; Wang Y; Li W; Zhao X; Cheng Z; Xu N; Huang C; Liu G
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Mar; 20(3):283-288. PubMed ID: 28338161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma.
    Gaspar MJ; Arribas I; Coca MC; Díez-Alonso M
    Tumour Biol; 2001; 22(5):318-22. PubMed ID: 11553862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of tumor markers as predictors of prognosis in gastric cancer.
    Mihmanli M; Dilege E; Demir U; Coskun H; Eroglu T; Uysalol MD
    Hepatogastroenterology; 2004; 51(59):1544-7. PubMed ID: 15362797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative serum CEA and CA19-9 in gastric cancer--a single tertiary hospital study of 1,075 cases.
    Zhou YC; Zhao HJ; Shen LZ
    Asian Pac J Cancer Prev; 2015; 16(7):2685-91. PubMed ID: 25854347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Soluble Interleukin-2 Receptor Levels in Patients with Breast Cancer.
    Murakami S; Hirayama R; Satomi A; Okubo K; Matsuki M; Sakata H; Tsuji Y
    Breast Cancer; 1997 Mar; 4(1):25-28. PubMed ID: 11091572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of serum and tissue carcinoembryonic antigen for the prognosis of gastric carcinoma patients.
    Kim DY; Kim HR; Shim JH; Park CS; Kim SK; Kim YJ
    J Surg Oncol; 2000 Jul; 74(3):185-92. PubMed ID: 10951413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of preoperative serum anti-p53 antibodies in gastric cancer.
    Nakajima K; Suzuki T; Shimada H; Hayashi H; Takeda A; Ochiai T
    Tumour Biol; 1999; 20(3):147-52. PubMed ID: 10213922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.